Last reviewed · How we verify
Placebo matching nitrofurantoin — Competitive Intelligence Brief
phase 3
Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo matching nitrofurantoin (Placebo matching nitrofurantoin) — GlaxoSmithKline. This is a placebo control formulation matching the appearance and characteristics of nitrofurantoin, used in clinical trials to provide a blinded comparator.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo matching nitrofurantoin TARGET | Placebo matching nitrofurantoin | GlaxoSmithKline | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo matching nitrofurantoin CI watch — RSS
- Placebo matching nitrofurantoin CI watch — Atom
- Placebo matching nitrofurantoin CI watch — JSON
- Placebo matching nitrofurantoin alone — RSS
Cite this brief
Drug Landscape (2026). Placebo matching nitrofurantoin — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-matching-nitrofurantoin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab